Fourth-generation fluoroquinolones in tuberculosis

Lancet. 2009 Apr 4;373(9670):1148-9. doi: 10.1016/S0140-6736(09)60559-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Infective Agents / therapeutic use*
  • Aza Compounds / therapeutic use*
  • Drug Administration Schedule
  • Drug Discovery
  • Drug Therapy, Combination
  • Fluoroquinolones
  • Humans
  • Moxifloxacin
  • Quinolines / therapeutic use*
  • Sputum / microbiology
  • Time Factors
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Moxifloxacin